Methods for evaluating suitability of a biochemical filter

Patent metadata

Field	Value
Publication number	US-11378571-B2
Application number	US-201916395431-A
Country	US
Kind code	B2
Filing date	Apr 26, 2019
Priority date	May 2, 2018
Publication date	Jul 5, 2022
Grant date	Jul 5, 2022

Abstract

Embodiments of the present disclosure include methods and systems for detecting the presence of endotoxins in filters. For example, embodiments of the present disclosure are directed to methods and systems for improving in-process controls by detecting undesirable quantities of endotoxins in filters containing naturally-sourced materials prior to using those filters in the production of formulated drug substances.

First claim

What is claimed is:

1. A method for evaluating suitability of a plurality of filters for use in a biologic purification process, the method comprising:
selecting a filter from the plurality of filters, wherein each of the plurality of filters comprises cellulose;
passing a volume of a buffer solution through the selected filter, wherein the buffer solution has a conductivity of at least about 40 mS/cm at 25° C. when tested in accordance with ASTM D1125, and the buffer solution is configured to remove endotoxins from the selected filter;
performing an assay of the buffer solution passed through the selected filter to detect a presence of an endotoxin removed from the selected filter;
evaluating the suitability of the plurality of filters for use in the biologic purification process based on a result of the assay; and
repeating the selecting, passing, performing, and evaluating steps at periodic time intervals.

2. The method of claim 1 , wherein the evaluating step comprises at least one of:
approving the plurality of filters for use in the biologic purification process if a quantity of endotoxin in the buffer solution passed through the selected filter is below a first predetermined threshold; or
rejecting the plurality of filters for use in the biologic purification process if the quantity of endotoxin in the buffer solution passed through the selected filter is above a second predetermined threshold.

3. The method of claim 1 , wherein the buffer solution comprises sodium phosphate.

4. The method of claim 1 , wherein the plurality of filters comprises a plurality of harvest depth filters.

5. A method for detecting presence of an endotoxin, the method comprising:
contacting a naturally-sourced material with a buffer solution, wherein the naturally-sourced material comprises cellulose, and wherein the buffer solution is configured to remove the endotoxin from the naturally-sourced material; and
performing an assay of the buffer solution passed through the naturally-sourced material to detect a presence of the endotoxin removed from the naturally-sourced material in the buffer solution,
wherein the buffer solution comprises tris(hydroxymethyl)aminomethane, citrate, histidine, arginine, or mixtures thereof.

6. The method of claim 5 , further comprising:
after contacting the naturally-sourced material with the buffer solution, contacting the naturally-sourced material with a cell culture fluid.

7. The method of claim 5 , wherein the buffer solution is configured to disrupt one of an electrostatic interaction or a hydrophobic interaction between the endotoxin and the naturally-sourced material.

8. The method of claim 5 , wherein the buffer solution further comprises phosphate.

9. The method of claim 5 , wherein the step of contacting the naturally-sourced material with a buffer solution comprises passing at least 25 L/m 2 of the buffer solution through a filter that comprises the naturally-sourced material.

10. The method of claim 5 , further comprising:
after contacting the naturally-sourced material with the buffer solution, contacting the naturally-sourced material with water for injection (WFI); and
performing an assay on the WFI to detect the endotoxin in the WFI.

11. The method of claim 5 , wherein the assay is one of a Limulus Amebocyte Lysate assay or a fluorescent assay.

12. A method for determining suitability of a buffer solution for use in an endotoxin detection process, the method comprising:
passing the buffer solution through a first filter of a filter lot, the filter lot including a plurality of filters comprising naturally-sourced materials, wherein the buffer solution comprises tris(hydroxymethyl)aminomethane, citrate, histidine, arginine, or mixtures thereof, and the buffer solution is configured to remove the endotoxin from the first filter via disrupting one of an electrostatic interaction or a hydrophobic interaction between the endotoxin and the first filter;
assaying the buffer solution passed through the first filter to detect a quantity of the endotoxin removed from the first filter and present in the buffer solution;
passing a cell culture fluid through a second filter of the filter lot;
assaying the cell culture fluid passed through the second filter to detect a quantity of the endotoxin removed from the second filter and present in the cell culture fluid; and
comparing the quantity of the endotoxin detected in the buffer solution to the quantity of the endotoxin detected in the cell culture fluid.

13. The method of claim 12 , wherein the naturally-sourced materials include one of cellulose and diatomaceous earth.

14. The method of claim 12 , wherein assaying the cell culture fluid comprises assaying a clarified pool of the cell culture fluid.

15. The method of claim 12 , further comprising:
determining a threshold quantity of endotoxin based on the quantity of the endotoxin detected in the cell culture fluid passed through the second filter; and
if the quantity of the endotoxin detected in the buffer solution passed through the first filter is above the threshold quantity, approving the buffer solution for use in the endotoxin detection process.

16. A method, the method comprising:
passing at least 25 L/m 2 of a buffer solution through a filter, wherein the buffer solution is configured to remove endotoxins from the filter, thereby washing endotoxins from the filter before use, and
assaying the buffer solution passed through the filter, wherein the buffer solution has a conductivity of at least about 40 mS/cm at 25° C. when tested in accordance with ASTM D1125,
wherein the filter is a harvest depth filter, the harvest depth filter comprises naturally-sourced materials and the naturally-sourced materials comprise cellulose.

17. The method of claim 16 , further comprising:
after passing the buffer solution through the filter, passing a volume of cell culture fluid through the filter.

18. The method of claim 16 , wherein the buffer solution comprises sodium phosphate at a concentration of about 10 mM.

19. The method of claim 16 , wherein the harvest depth filter further comprises diatomaceous earth.

20. The method of claim 2 , wherein the first predetermined threshold of the quantity of endotoxin in the buffer solution passed through the selected filter for approving the plurality of filters is at least about 0.34 EU/mL.

21. The method of claim 2 , wherein the second predetermined threshold of the quantity of endotoxin in the buffer solution passed through the selected filter for rejecting the plurality of filters is at least about 0.90 EU/mL.

Assignees

• Regeneron Pharma

Inventors

• Mao Nathan
• Cruz Annamarie
• Schilling Bernhard
• Carver Scott

Classifications

• C12M37/02

  Filters · CPC title

• G01N33/538 Primary

  by sorbent column, particles or resin strip {, i.e. sorbent materials} · CPC title

• G01N33/582

  with fluorescent label · CPC title

• G01N33/5014 Primary

  for testing toxicity · CPC title

• B01D15/38 Primary

  involving specific interaction not covered by one or more of groups {B01D15/265 and} B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography · CPC title